The COVID-19 pandemic has underscored the critical importance of resilient vaccine supply chains in safeguarding global health. Traditional manufacturing methods often struggle to meet the demands of rapidly evolving pathogens and unpredictable disruptions. In response, modular manufacturing emerges as a promising solution, offering agility, scalability and adaptability. This article explores the role of modular manufacturing in bolstering the resilience of vaccine supply chains, highlighting its benefits, challenges and implications for future pandemic preparedness.
HTML PDFShare this article
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report
